An interventional study of Rocuronium (MB group) and Rocuronium (DB group) in Cholecystectomy, Laparoscopic, sponsored by Seoul National University Bundang Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2018-10-26.
Sponsored by Seoul National University Bundang Hospital · Not applicable, Interventional, and Diagnostic
The purpose of this study is to evaluated whether the depth of neuromuscular block may affect the unicon value of anesthetic depth monitoring system (ADMS).
Seoul National University Bundang Hospital is the lead sponsor of 368 studies on the registry; 55 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Rocuronium (MB group)
Drug: Rocuronium (DB group)
Count of train-of-four: 1-2 Titration of rocuronium dose
Post-tetanic count: 1-2 Titration of rocuronium dose
Total infused dose of propofol
Time frame: At 1 min after the anesthesia is finished
Electromyographic index presented on the anesthetic depth monitoring system
Time frame: Through study completion, an average of 2 hours
This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Bundang Hospital